Ranbaxy Recalls Atorvastatin Calcium Tablets Due to Glass Particulates
Ranbaxy Inc. is recalling specific lots of Atorvastatin Calcium tablets because they may contain small glass particulates.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of glass particulates in oral medication poses a risk of significant injury, meeting the criteria for a Severe rating.
Plain-English summary
Ranbaxy Inc. is recalling specific lots of Atorvastatin Calcium tablets, 40 mg, in 90-count and 500-count bottles. The recall is due to the presence of small glass particulates in certain batches of Atorvastatin tablets.
The affected product is a prescription-only medication manufactured for Ranbaxy Pharmaceuticals Inc. and distributed nationwide and in Puerto Rico. The recall covers 157,026 bottles across specific lot numbers with expiration dates in July and August 2014.
Consumers should check their medication bottles for the specific lot numbers listed in the recall notice. If the lot number matches, they should stop using the medication and contact their healthcare provider or pharmacist for guidance on obtaining a replacement.
The recalled product
- Product
- ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Ranbaxy Inc.
- Category
- Drug — Prescription Medication
- Affected units
- 157,026
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- a) 40 mg 90 count
- Lot #s: 2434265
- 2434266
- 2434824
- 2434826
- 2434827
- 2434828
- 2434829
- 2434830
- 2434831
- Exp 07/31/2014
- 2436580
- 2436725
- 2436727
- 2436729
- 2437377
- 2437380
- 2437941
- 2437943
- 2437944
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Ranbaxy Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · ATORVASTATIN CALCIUM
- ModerateAtorvastatin 40 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 10 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 80 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin 20 mg tablets recalled after failing dissolution specifications
FDA (Drugs) · 2025-10-22
- HighBiocon Pharma atorvastatin calcium tablets recalled for failed dissolution specifications
FDA (Drugs) · 2025-04-09
Same manufacturer · Ranbaxy Inc.
See all →- ModerateRanbaxy Recalls Absorica LD Isotretinoin Capsules Due to Undeclared Dye
FDA (Drugs) · 2015-08-12
- ModerateRanbaxy Recalls Atorvastatin Calcium Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2014-03-05
- LowRanbaxy Recalls Lac-Hydrin Cream Due to Crystallization
FDA (Drugs) · 2013-02-20
- LowRanbaxy Recalls Lac-Hydrin Lotion Due to Crystallization Texture
FDA (Drugs) · 2013-02-20
- HighRanbaxy Recalls Atorvastatin Calcium Tablets Due to Glass Particulates
FDA (Drugs) · 2012-12-05
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02